![Sativex oromucosal cannabis based medicine (photo: Ethan Russo , 2003) | Download Scientific Diagram Sativex oromucosal cannabis based medicine (photo: Ethan Russo , 2003) | Download Scientific Diagram](https://www.researchgate.net/publication/6126756/figure/fig1/AS:277764411281430@1443235604530/Sativex-oromucosal-cannabis-based-medicine-photo-Ethan-Russo-2003.png)
Sativex oromucosal cannabis based medicine (photo: Ethan Russo , 2003) | Download Scientific Diagram
![Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience | BMC Neurology | Full Text Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-021-02246-0/MediaObjects/12883_2021_2246_Fig2_HTML.png)
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience | BMC Neurology | Full Text
![Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity | Semantic Scholar Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb6a0c04b1b19516d510044bf643b98ce8220760/6-Figure3-1.png)
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity | Semantic Scholar
![Study: Short-Term Use of Prescription Medication Containing THC and CBD Not Associated with Cardiovascular Complications in High-Risk Patients - NORML Study: Short-Term Use of Prescription Medication Containing THC and CBD Not Associated with Cardiovascular Complications in High-Risk Patients - NORML](https://i0.wp.com/norml.org/wp-content/uploads/2022/03/sativex-spray.jpg?fit=730%2C411&ssl=1)
Study: Short-Term Use of Prescription Medication Containing THC and CBD Not Associated with Cardiovascular Complications in High-Risk Patients - NORML
![A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01259-3/MediaObjects/41416_2021_1259_Fig1_HTML.png)
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer
![5G•WiFi INSIDE SECURE IRIS BIOMETRICS' LOGIN on X: "#facepalbook #Sativex (# Nabiximols) an #oromucosal (#mouth_spray), and the world's first prescription medicine derived from extracts of the cannabis (marijuana) plant may be prescribe for: 5G•WiFi INSIDE SECURE IRIS BIOMETRICS' LOGIN on X: "#facepalbook #Sativex (# Nabiximols) an #oromucosal (#mouth_spray), and the world's first prescription medicine derived from extracts of the cannabis (marijuana) plant may be prescribe for:](https://pbs.twimg.com/media/EEMOdjKXYA825q6.png)